Northwire Canada EditionTuesday, July 14, 2026
Sign inSubscribe
Northwire
⌕
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%
M&A / Property Routine +

Psyence Group Inc. Announces Amendment to Amalgamation Agreement with GoldCoast Resource Corp.

Psyence Advances GoldCoast Merger Amidst Trading Halt; Shareholder Vote Set for May

By The Northwire Desk — AI Analysis Apr 23, 2026 · 18:30 PSYG · 0.12 Psyence Group Inc.
Executive Summary
  • Amalgamation Amendment: Psyence Group Inc. announced an amendment to its amalgamation agreement with GoldCoast Resource Corp., revising the share consolidation formula to account for time lapse and equity values at closing.
  • Shareholder Meeting: An annual and special meeting is scheduled for May 19, 2026, to approve the transaction and proposed share consolidation.
  • Transaction Structure: GoldCoast and Psyence Subco will amalgamate under Ontario law; Psyence continues as the resulting issuer but pivots from biotechnology to offshore gold exploration in Ghana.
  • Consolidation Formula: One new Psyence Share issued for every (A/B) x C pre-consolidation shares, where A is current share count (16,129,406), B includes cash + expenses + $1.5M + loan value, and C is GoldCoast issue price ($0.85).
  • Conditions: Closing remains subject to shareholder approval, Canadian Securities Exchange (CSE) approval, and other customary conditions.
Material Impact
  • Deal Progression: The news confirms the transaction is moving forward towards a May 31, 2026 closing date, following the satisfaction of financing conditions in March ($8.6M raised).
  • Shareholder Dilution Risk: GoldCoast shareholders are projected to own ~90%-95% of the resulting issuer; Psyence shareholders face significant dilution or consolidation adjustments based on the complex formula provided.
  • Trading Status: Shares remain halted pending CSE approval and completion of amalgamation, as noted in previous February news and reflected in stagnant price data ($0.12 flatline).
  • Business Pivot: Fundamental change from biotechnology to gold exploration introduces sector-specific risks not previously priced into the biotech valuation.
  • Routine Nature: The financing condition was met in March; this April update is procedural (meeting date, formula adjustment) rather than a new value driver.
PSYG · Price
Company Overview
  • Current Business: Psyence Group Inc. was originally focused on biotechnology but is transitioning to offshore gold exploration via amalgamation with GoldCoast Resource Corp.
  • Flagship Project: GoldCoast's offshore reconnaissance licenses covering ~10,000 km² on Ghana's western offshore continental shelf (granted Jan 2026).
  • Development Stage: Reconnaissance phase; potential progression to prospecting and mining licences subject to exploration results and regulatory approvals.
Read the original news release →

More from Psyence Group Inc.

May 21, 2026 · 19:00

Psyence Shareholders Approve GoldCoast Amalgamation; CSE Approval Remains Key Hurdle

M&A / Property Mar 25, 2026 · 04:31

Psyence Advances RTO with GoldCoast as $8.6M Financing Clears Key Hurdle

Financings Mar 17, 2026 · 23:15

Psyence target GoldCoast closes $5.82-million financing

Financings Mar 17, 2026 · 19:00

Psyence Group Inc. Provides Update on Proposed Amalgamation with GoldCoast Resource Corp.

Financings Feb 24, 2026 · 06:00

Psyence Group Inc. Enters into Amending Agreement to Extend Amalgamation Timeline with GoldCoast Resource Corp.

Other Jan 27, 2026 · 18:34

Psyence RTO target receives reconnaissance licences

M&A / Property